Duke Glioma Handbook Pathology Diagnosis and Management
Immunotherapy for gliomas
Publication
, Chapter
Fecci, PE; Riccione, K; Dunn, GP; Reap, E; Vlahovic, G; Congdon, K; Sampson, JH
March 31, 2016
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Fecci, P. E., Riccione, K., Dunn, G. P., Reap, E., Vlahovic, G., Congdon, K., & Sampson, J. H. (2016). Immunotherapy for gliomas. In Duke Glioma Handbook Pathology Diagnosis and Management (pp. 91–120). https://doi.org/10.1017/CBO9781107588721.006
Fecci, P. E., K. Riccione, G. P. Dunn, E. Reap, G. Vlahovic, K. Congdon, and J. H. Sampson. “Immunotherapy for gliomas.” In Duke Glioma Handbook Pathology Diagnosis and Management, 91–120, 2016. https://doi.org/10.1017/CBO9781107588721.006.
Fecci PE, Riccione K, Dunn GP, Reap E, Vlahovic G, Congdon K, et al. Immunotherapy for gliomas. In: Duke Glioma Handbook Pathology Diagnosis and Management. 2016. p. 91–120.
Fecci, P. E., et al. “Immunotherapy for gliomas.” Duke Glioma Handbook Pathology Diagnosis and Management, 2016, pp. 91–120. Scopus, doi:10.1017/CBO9781107588721.006.
Fecci PE, Riccione K, Dunn GP, Reap E, Vlahovic G, Congdon K, Sampson JH. Immunotherapy for gliomas. Duke Glioma Handbook Pathology Diagnosis and Management. 2016. p. 91–120.